Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

MPN Advances Day 2019 E-Learning

Keep up-to-date with the latest advances in MPNs!

The Myeloproliferative Neoplasms (MPN) Advances Day 2019 took place on 15 November, in London, UK. Leading experts came together to present recent advances in understanding the disease biology of MPNs and how they can be treated, providing an opportunity for clinicians to keep abreast of the field.

Key topics from the meeting included essential thrombocythemia (ET), polycythemia vera, myelofibrosis, and atypical MPNs. Presentation topics included clonal hemopoiesis to leukemia, novel therapies for mastocytosis, and what new therapies can offer MPN patients.
View e-learning webcasts from all three sessions below.

Session 1

Featured Presentation:

From Clonal Haemopoiesis
to Leukemia

Adam Mead

New Insights into the Management of ET
Mary Frances McMullin
BSH Guidelines for Non-Clonal Erythrocytosis
Mary Frances McMullin Queen's University Belfast, Belfast, United Kingdom
Jean-Jacques  Kiladjian
Current and Future Therapies for Polycythemia Vera
Jean-Jacques Kiladjian Saint-Louis Hospital & Paris Diderot University, Paris, France

Session 2

Featured Presentation:

Systemic Mastocytosis: New Treatments

Mark Drummond

Andreas Reiter
Atypical MPNs: Focus on CNL and 8p11 Disease
Andreas Reiter University Medical Centre Mannheim, Mannheim, Germany
Arjun Ghosh
Cardiology Updates for Hematologists
Arjun Ghosh University College London, London, United Kingdom

Session 3

Featured Presentation:

What can New Therapies Offer MPN Patients?

Claire Harrison

The Challenges of AML Following MPNs
Ruben Mesa
Medical Management of Myelofibrosis
Ruben Mesa Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, United States

Related Content on VJHemOnc